| Impact of remote telemedical management on mortality and hospitalizations in ambulatory patients with chronic heart failure: the telemedical interventional monitoring in heart … F Koehler, S Winkler, M Schieber, U Sechtem, K Stangl, M Böhm, H Boll, ... Circulation 123 (17), 1873-1880, 2011 | 782 | 2011 |
| Efficacy of telemedical interventional management in patients with heart failure (TIM-HF2): a randomised, controlled, parallel-group, unmasked trial F Koehler, K Koehler, O Deckwart, S Prescher, K Wegscheider, BA Kirwan, ... The Lancet 392 (10152), 1047-1057, 2018 | 603 | 2018 |
| Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the … DJFM Thuijs, AP Kappetein, PW Serruys, FW Mohr, MC Morice, MJ Mack, ... The Lancet 394 (10206), 1325-1334, 2019 | 533 | 2019 |
| A constituent of green tea, epigallocatechin-3-gallate, activates endothelial nitric oxide synthase by a phosphatidylinositol-3-OH-kinase-, cAMP-dependent protein kinase-, and … M Lorenz, S Wessler, E Follmann, W Michaelis, T Düsterhöft, G Baumann, ... Journal of Biological Chemistry 279 (7), 6190-6195, 2004 | 443 | 2004 |
| A Constituent of Green Tea, Epigallocatechin-3-gallate, Activates Endothelial Nitric Oxide Synthase by a Phosphatidylinositol-3-OH-kinase-, cAMP-dependent Protein Kinase-, and … G Baumann, K Stangl, V Stangl | 443* | 2004 |
| Female-specific aspects in the pharmacotherapy of chronic cardiovascular diseases N Jochmann, K Stangl, E Garbe, G Baumann, V Stangl European heart journal 26 (16), 1585-1595, 2005 | 418 | 2005 |
| Use of metoprolol CR/XL to maintain sinus rhythm after conversion from persistent atrial fibrillation: a randomized, double-blind, placebo-controlled study V Kühlkamp, A Schirdewan, K Stangl, M Homberg, M Ploch, OA Beck Journal of the American College of Cardiology 36 (1), 139-146, 2000 | 379 | 2000 |
| Use of metoprolol CR to maintain sinus rhythm after conversion from persistent atrial fibrillation. A randomized double-blind placebo-controlled study V Kuehlkamp, A Schirdewan, K Stangl, M Homberg, M Ploch, OA Beck Circulation 98 (17), 633-633, 1998 | 379 | 1998 |
| Inhibition of proteasome activity induces concerted expression of proteasome genes and de novo formation of mammalian proteasomes S Meiners, D Heyken, A Weller, A Ludwig, K Stangl, PM Kloetzel, ... Journal of Biological Chemistry 278 (24), 21517-21525, 2003 | 365 | 2003 |
| Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy: three-month results from a randomized study SB Felix, A Staudt, WV Dörffel, V Stangl, K Merkel, M Pohl, WD Döcke, ... Journal of the American College of Cardiology 35 (6), 1590-1598, 2000 | 353 | 2000 |
| The role of tea and tea flavonoids in cardiovascular health V Stangl, M Lorenz, K Stangl Molecular nutrition & food research 50 (2), 218-228, 2006 | 325 | 2006 |
| Molecular targets of tea polyphenols in the cardiovascular system V Stangl, H Dreger, K Stangl, M Lorenz Cardiovascular research 73 (2), 348-358, 2007 | 314 | 2007 |
| Superiority of ibutilide (a new class III agent) overdl-sotalol in converting atrial flutter and atrial fibrillation MA Vos, SR Golitsyn, K Stangl, MY Ruda, L Van Wijk, JD Harry, KT Perry, ... Heart 79 (6), 568-575, 1998 | 267 | 1998 |
| The pregnancy hormone relaxin is a player in human heart failure T Dschietzig, C Richter, C Bartsch, M Laule, FP Armbruster, G Baumann, ... The FASEB Journal 15 (12), 2187-2195, 2001 | 265 | 2001 |
| Immunohistological changes in dilated cardiomyopathy induced by immunoadsorption therapy and subsequent immunoglobulin substitution A Staudt, F Schäper, V Stangl, A Plagemann, M Böhm, K Merkel, ... Circulation 103 (22), 2681-2686, 2001 | 255 | 2001 |
| Removal of cardiodepressant antibodies in dilated cardiomyopathy by immunoadsorption SB Felix, A Staudt, M Landsberger, Y Grosse, V Stangl, T Spielhagen, ... Journal of the American College of Cardiology 39 (4), 646-652, 2002 | 249 | 2002 |
| Nrf2-dependent upregulation of antioxidative enzymes: a novel pathway for proteasome inhibitor-mediated cardioprotection H Dreger, K Westphal, A Weller, G Baumann, V Stangl, S Meiners, ... Cardiovascular research 83 (2), 354-361, 2009 | 244 | 2009 |
| Coronary atherogenic risk factors in women V Stangl, G Baumann, K Stangl European Heart Journal 23 (22), 1738-1752, 2002 | 240 | 2002 |
| The tea flavonoid epigallocatechin-3-gallate reduces cytokine-induced VCAM-1 expression and monocyte adhesion to endothelial cells A Ludwig, M Lorenz, N Grimbo, F Steinle, S Meiners, C Bartsch, K Stangl, ... Biochemical and biophysical research communications 316 (3), 659-665, 2004 | 239 | 2004 |
| HnRNP L stimulates splicing of the eNOS gene by binding to variable-length CA repeats J Hui, K Stangl, WS Lane, A Bindereif Nature structural biology 10 (1), 33-37, 2003 | 226 | 2003 |
